Candida albicans and Enterococcus faecalis in the gut: Synergy in commensalism?

Gut Microbes

Volumn 4, Issue 5, 2013, Pages 409-415

  Garsin, Danielle A ^a   Lorenz, Michael C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

C. elegans; Candida; Enterococcus; Hyphal morphogenesis; Microbiome

Indexed keywords

CEFOPERAZONE; DNA 16S; PHENAZINE DERIVATIVE;

ANTIBIOSIS; ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; COMMENSALISM; ENTERITIS; ENTEROCOCCUS FAECALIS; FUNGICIDAL ACTIVITY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INTESTINE INFECTION; LACTIC ACID BACTERIUM; MICROBIOME; MIXED INFECTION; MORPHOGENESIS; NEMATODE MODEL; NONHUMAN; STREPTOCOCCUS MUTANS; TISSUE INJURY; VENTILATOR ASSOCIATED PNEUMONIA; ANIMAL; C. ELEGANS; CANDIDA; CANDIDIASIS; ENTEROCOCCUS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; HYPHAL MORPHOGENESIS; METABOLISM; MICROBIOLOGY; NOTE; PATHOGENICITY;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; CANDIDA; CANDIDA ALBICANS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FUNGI; POSIBACTERIA;

C. ELEGANS; CANDIDA; ENTEROCOCCUS; HYPHAL MORPHOGENESIS; MICROBIOME;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; COINFECTION; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS;

EID: 84883345687     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.26040     Document Type: Article

References (52)

1. Hermans PE, Washington JA 2nd. Polymicrobial bacteremia. Ann Intern Med 1970; 73:387-92; PMID:4917179; http://dx.doi.org/10.7326/0003-4819-73-3-387
2. McKenzie FE. Case mortality in polymicrobial bloodstream infections. J Clin Epidemiol 2006; 59:760-1; PMID:16765282; http://dx.doi.org/10.1016/j.jclinepi. 2005.12.009
3. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis 2007; 45:228-33; PMID:17578784; http://dx.doi. org/10.1086/518873
4. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989; 11:74-85; PMID:2916096; http://dx.doi. org/10.1093/clinids/11.1.74
5. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 2007; 59:401-6; PMID:17888612; http://dx.doi.org/10.1016/j. diagmicrobio.2007.07.001
6. Sutter D, Stagliano D, Braun L, Williams F, Arnold J, Ottolini M, Epstein J. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management. Pediatr Infect Dis J 2008; 27:400-5; PMID:18398386; http:// dx.doi.org/10.1097/INF.0b013e31816591be
7. Hermann C, Hermann J, Munzel U, Rüchel R. Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses 1999; 42:619-27; PMID:10680438; http://dx.doi.org/10.1046/j.1439-0507.1999.00519.x
8. Marsh EK, May RC. Caenorhabditis elegans, a model organism for investigating immunity. Appl Environ Microbiol 2012; 78:2075-81; PMID:22286994; http://dx.doi.org/10.1128/AEM.07486-11
9. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 2007; 3:e18; PMID:17274686; http://dx.doi. org/10.1371/journal.ppat.0030018
10. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci U S A 2001; 98:10892-7; PMID:11535834; http://dx.doi.org/10.1073/ pnas.191378698
11. Maadani A, Fox KA, Mylonakis E, Garsin DA. Enterococcus faecalis mutations affecting virulence in the Caenorhabditis elegans model host. Infect Immun 2007; 75:2634-7; PMID:17307944; http:// dx.doi.org/10.1128/IAI.01372-06
12. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr., Mylonakis E. Prokaryoteeukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci U S A 2008; 105:14585-90; PMID:18794525; http:// dx.doi.org/10.1073/pnas.0805048105
13. Cruz MR, Graham CE, Gagliano BC, Lorenz MC, Garsin DA. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun 2013; 81:189-200; PMID:23115035; http://dx.doi.org/10.1128/IAI.00914-12
14. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004; 54:1212-23; PMID:15554963; http://dx.doi.org/10.1111/ j.1365-2958.2004.04349.x
15. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 2008; 67:47-62; PMID:18078440; http://dx.doi. org/10.1111/j.1365-2958.2007.06013.x
16. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R, Dussault P, Nickerson KW. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 2001; 67:2982-92; PMID:11425711; http://dx.doi. org/10.1128/AEM.67.7.2982-2992.2001
17. Boon C, Deng Y, Wang LH, He Y, Xu JL, Fan Y, Pan SQ, Zhang LH. A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J 2008; 2:27-36; PMID:18049456; http://dx.doi. org/10.1038/ismej.2007.76
18. Wang LH, He Y, Gao Y, Wu JE, Dong YH, He C, Wang SX, Weng LX, Xu JL, Tay L, et al. A bacterial cell-cell communication signal with cross-kingdom structural analogues. Mol Microbiol 2004; 51:903-12; PMID:14731288; http://dx.doi.org/10.1046/ j.1365-2958.2003.03883.x
19. Morales DK, Grahl N, Okegbe C, Dietrich LE, Jacobs NJ, Hogan DA. Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines. MBio 2013; 4:e00526-12; PMID:23362320; http://dx.doi.org/10.1128/ mBio.00526-12
20. Tampakakis E, Peleg AY, Mylonakis E. Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium. Eukaryot Cell 2009; 8:732-7; PMID:19329669; http://dx.doi. org/10.1128/EC.00016-09
21. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol 2010; 59:493-503; PMID:20608978
22. Pereira-Cenci T, Deng DM, Kraneveld EA, Manders EM, Del Bel Cury AA, Ten Cate JM, Crielaard W. The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. Arch Oral Biol 2008; 53:755-64; PMID:18395698; http://dx.doi.org/10.1016/j.archoralbio. 2008.02.015
23. Jarosz LM, Deng DM, van der Mei HC, Crielaard W, Krom BP. Streptococcus mutans competencestimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell 2009; 8:1658-64; PMID:19717744; http://dx.doi.org/10.1128/ EC.00070-09
24. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, Jenkinson HF. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 2009; 77:3696-704; PMID:19528215; http://dx.doi. org/10.1128/IAI.00438-09
25. Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, et al.; Outcomerea Study Group. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 2006; 129:110-7; PMID:16424420; http://dx.doi.org/10.1378/ chest.129.1.110
26. Neely AN, Law EJ, Holder IA. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect Immun 1986; 52:200-4; PMID:2420722
27. Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 2009; 53:3914-22; PMID:19564370; http://dx.doi.org/10.1128/AAC.00657-09
28. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997; 90:939-49; PMID:9298905; http://dx.doi.org/10.1016/S0092-8674(00)80358-X
29. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 2:1053-60; PMID:14555488; http://dx.doi. org/10.1128/EC.2.5.1053-1060.2003
30. Mylonakis E, Engelbert M, Qin X, Sifri CD, Murray BE, Ausubel FM, Gilmore MS, Calderwood SB. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun 2002; 70:4678-81; PMID:12117982; http:// dx.doi.org/10.1128/IAI.70.8.4678-4681.2002
31. Qin X, Singh KV, Weinstock GM, Murray BE. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J Bacteriol 2001; 183:3372-82; PMID:11344145; http://dx.doi.org/10.1128/ JB.183.11.3372-3382.2001
32. Sifri CD, Mylonakis E, Singh KV, Qin X, Garsin DA, Murray BE, Ausubel FM, Calderwood SB. Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun 2002; 70:5647-50; PMID:12228293; http://dx.doi.org/10.1128/ IAI.70.10.5647-5650.2002
33. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 2004; 72:4996-5003; PMID:15321991; http://dx.doi. org/10.1128/IAI.72.9.4996-5003.2004
34. Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011; 9:233-43; PMID:21358670; http://dx.doi.org/10.1038/nrmicro2536
35. Mason KL, Erb Downward JR, Falkowski NR, Young VB, Kao JY, Huffnagle GB. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun 2012; 80:150-8; PMID:21986629; http://dx.doi.org/10.1128/IAI.05162-11
36. Mason KL, Erb Downward JR, Mason KD, Falkowski NR, Eaton KA, Kao JY, Young VB, Huffnagle GB. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun 2012; 80:3371-80; PMID:22778094; http://dx.doi. org/10.1128/IAI.00449-12
37. Carlson E. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect Immun 1983; 39:193-7; PMID:6401691
38. Peters BM, Noverr MC. Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect Immun 2013; 81:2178-89; PMID:23545303; http://dx.doi.org/10.1128/ IAI.00265-13
39. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002; PMID:22002980; http://dx.doi.org/10.1093/cid/ cir632
40. Van Kessel K, Assefi N, Marrazzo J, Eckert L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstet Gynecol Surv 2003; 58:351-8; PMID:12719677; http://dx.doi.org/10.1097/01. OGX.0000068791.04785.8D
41. Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio 2013; 4:e00076; PMID:23592260; http://dx.doi.org/10.1128/mBio.00076-13
42. Song SJ, Lauber C, Costello EK, Lozupone CA, Humphrey G, Berg-Lyons D, Caporaso JG, Knights D, Clemente JC, Nakielny S, et al. Cohabiting family members share microbiota with one another and with their dogs. Elife 2013; 2:e00458; PMID:23599893; http://dx.doi.org/10.7554/eLife.00458
43. Project HMC; Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012; 486:215-21; PMID:22699610; http://dx.doi.org/10.1038/ nature11209
44. Project HMC; Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14; PMID:22699609; http://dx.doi.org/10.1038/ nature11234
45. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, Kong HH, et al.; NIH Intramural Sequencing Center Comparative Sequencing Program. Topographic diversity of fungal and bacterial communities in human skin. Nature 2013; 498:367-70; PMID:23698366; http://dx.doi. org/10.1038/nature12171
46. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 2007; 3:e184; PMID:18069889; http://dx.doi. org/10.1371/journal.ppat.0030184
47. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010; 6:e1000713; PMID:20072605; http://dx.doi.org/10.1371/journal. ppat.1000713
48. Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and-independent analysis of faeces. ISME J 2008; 2:1183-93; PMID:18670396; http://dx.doi.org/10.1038/ ismej.2008.76
49. Chen Y, Chen Z, Guo R, Chen N, Lu H, Huang S, Wang J, Li L. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Microbiol Infect Dis 2011; 70:492-8; PMID:20846815; http://dx.doi.org/10.1016/j. diagmicrobio.2010.04.005
50. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol 2008; 43:831-41; PMID:18584522; http://dx.doi.org/10.1080/00365520801935434
51. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 inf luence colitis. Science 2012; 336:1314-7; PMID:22674328; http://dx.doi.org/10.1126/science. 1221789
52. Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol 2010; 8:340-9; PMID:20348933; http:// dx.doi.org/10.1038/nrmicro2313